A Phase 2 Study to Explore the Efficacy and Safety of HB0017 Longer Dose Interval in Psoriasis Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This study is a randomized, double-blind phase 2 clinical trial aimed at exploring the efficacy, safety, and immunogenicity of HB0017 injection with different dosing regimens in the treatment of moderate to severe plaque psoriasis in subjects
Epistemonikos ID: bf20adf428141b72ca69ad0bac2c4c27320d2f98
First added on: Oct 01, 2024